<!DOCTYPE html>
<html lang="en">

<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Lesson 15.2: Advanced Hashimoto‚Äôs Immunology: Beyond the Basics</title>
    <style>
        /* Base & Reset */
        * {
            box-sizing: border-box;
        }

        body {
            font-family: Georgia, 'Times New Roman', serif;
            line-height: 1.8;
            color: #2d2d2d;
            background: #f8f6f3;
            margin: 0;
            padding: 0;
        }

        /* Main Container */
        .lesson-container {
            max-width: 860px;
            margin: 0 auto;
            padding: 40px 30px;
            background: #ffffff;
            min-height: 100vh;
            box-shadow: 0 0 60px rgba(0, 0, 0, 0.08);
        }

        /* Brand Header */
        .brand-header {
            text-align: center;
            padding-bottom: 30px;
            margin-bottom: 35px;
            border-bottom: 1px solid #eee;
        }

        .brand-logo {
            max-width: 220px;
            height: auto;
            margin-bottom: 5px;
        }

        /* Module Header - PURPLE/BLUE theme for Immunology Deep Dive */
        .module-header {
            background: linear-gradient(135deg, #4338ca 0%, #6366f1 100%);
            padding: 35px 35px 30px;
            border-radius: 16px;
            margin-bottom: 30px;
            position: relative;
            overflow: hidden;
        }

        .module-header::before {
            content: '';
            position: absolute;
            top: 0;
            right: 0;
            width: 300px;
            height: 300px;
            background: radial-gradient(circle, rgba(255, 255, 255, 0.1) 0%, transparent 70%);
            transform: translate(100px, -100px);
        }

        .module-header::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            width: 100%;
            height: 4px;
            background: linear-gradient(90deg, #B8860B, #D4A84B, #B8860B);
        }

        .module-label {
            margin: 0;
            font-size: 11px;
            color: rgba(255, 255, 255, 0.75);
            text-transform: uppercase;
            letter-spacing: 2.5px;
            font-weight: 500;
        }

        .lesson-title {
            margin: 10px 0 0 0;
            font-size: 28px;
            color: #ffffff;
            font-weight: 700;
            line-height: 1.3;
            position: relative;
        }

        .lesson-meta {
            display: flex;
            gap: 12px;
            margin-top: 20px;
            padding-top: 18px;
            border-top: 1px solid rgba(255, 255, 255, 0.15);
            flex-wrap: wrap;
        }

        .meta-item {
            display: flex;
            align-items: center;
            gap: 6px;
            font-size: 12px;
            color: rgba(255, 255, 255, 0.85);
            background: rgba(255, 255, 255, 0.1);
            padding: 5px 12px;
            border-radius: 4px;
        }

        /* Table of Contents */
        .toc-box {
            background: linear-gradient(135deg, #fafafa 0%, #f5f5f5 100%);
            border-radius: 14px;
            padding: 24px 28px;
            margin-bottom: 35px;
            border: 1px solid #e8e8e8;
        }

        .toc-box .box-label {
            font-weight: 600;
            color: #4338ca;
            margin: 0 0 18px 0;
            font-size: 12px;
            text-transform: uppercase;
            letter-spacing: 2px;
            padding-bottom: 12px;
            border-bottom: 1px solid #e0e0e0;
        }

        .toc-list {
            list-style: none;
            margin: 0;
            padding: 0;
            display: grid;
            grid-template-columns: repeat(2, 1fr);
            gap: 8px 24px;
        }

        .toc-list li {
            margin: 0;
        }

        .toc-list a {
            display: flex;
            align-items: center;
            padding: 8px 12px;
            color: #555;
            text-decoration: none;
            font-size: 14px;
            border-radius: 6px;
            transition: all 0.2s ease;
        }

        .toc-list a:hover {
            background: white;
            color: #4338ca;
            box-shadow: 0 2px 8px rgba(0, 0, 0, 0.06);
        }

        .toc-list .section-num {
            display: inline-flex;
            align-items: center;
            justify-content: center;
            width: 26px;
            height: 26px;
            background: #4338ca;
            color: white;
            font-weight: 600;
            font-size: 11px;
            border-radius: 6px;
            margin-right: 12px;
            flex-shrink: 0;
        }

        /* Learning Objectives */
        .objectives-box {
            background: #f5f3ff;
            border: 2px solid #6366f1;
            border-radius: 14px;
            padding: 30px 35px;
            margin-bottom: 40px;
        }

        .objectives-box .box-label {
            font-weight: 600;
            color: #4338ca;
            margin: 0 0 18px 0;
            font-size: 13px;
            text-transform: uppercase;
            letter-spacing: 2px;
            display: flex;
            align-items: center;
            gap: 10px;
        }

        .objectives-box .box-label::before {
            content: 'üéØ';
            font-size: 18px;
        }

        .objectives-box ul {
            margin: 0;
            padding-left: 22px;
        }

        .objectives-box li {
            margin-bottom: 14px;
            font-size: 16px;
            line-height: 1.7;
        }

        /* Section Headings */
        h2 {
            font-size: 24px;
            color: #1e1b4b;
            margin: 50px 0 20px 0;
            font-weight: 600;
            position: relative;
            padding-bottom: 12px;
        }

        h2::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            width: 60px;
            height: 3px;
            background: #B8860B;
        }

        h3 {
            font-size: 20px;
            color: #4338ca;
            margin: 30px 0 15px 0;
        }

        /* Paragraphs */
        p {
            font-size: 17px;
            margin-bottom: 20px;
            color: #333;
        }

        /* Highlights */
        .highlight {
            background: linear-gradient(180deg, transparent 60%, #e0e7ff 60%);
            padding: 0 4px;
            font-weight: 600;
            color: #1e1b4b;
        }

        /* Case Study Box */
        .case-study {
            background: linear-gradient(135deg, #f8f9fb 0%, #f0f2f5 100%);
            border-radius: 16px;
            padding: 0;
            margin: 40px 0;
            overflow: hidden;
            box-shadow: 0 4px 20px rgba(0, 0, 0, 0.06);
            border: 1px solid #e5e7eb;
        }

        .case-study-header {
            background: linear-gradient(135deg, #4338ca 0%, #6366f1 100%);
            padding: 20px 30px;
            display: flex;
            align-items: center;
            gap: 15px;
        }

        .case-study-icon {
            width: 45px;
            height: 45px;
            background: rgba(255, 255, 255, 0.15);
            border-radius: 10px;
            display: flex;
            align-items: center;
            justify-content: center;
            font-size: 22px;
        }

        .case-study-header .box-label {
            font-weight: 600;
            color: #ffffff;
            margin: 0;
            font-size: 16px;
            letter-spacing: 0.5px;
        }

        .case-study-content {
            padding: 28px 30px;
        }

        .patient-profile {
            display: flex;
            align-items: center;
            gap: 18px;
            padding: 18px 22px;
            background: white;
            border-radius: 12px;
            margin-bottom: 20px;
            border: 1px solid #e5e5e5;
        }

        .patient-avatar {
            width: 55px;
            height: 55px;
            background: linear-gradient(135deg, #6366f1, #4338ca);
            border-radius: 50%;
            display: flex;
            align-items: center;
            justify-content: center;
            font-size: 24px;
            flex-shrink: 0;
            color: white;
        }

        /* Statistics Box */
        .stats-box {
            background: linear-gradient(135deg, #1e1b4b 0%, #4338ca 100%);
            padding: 40px;
            border-radius: 16px;
            margin: 35px 0;
            color: white;
        }

        .stats-grid {
            display: grid;
            grid-template-columns: repeat(auto-fit, minmax(140px, 1fr));
            gap: 25px;
        }

        .stat-item {
            text-align: center;
        }

        .stat-number {
            font-size: 42px;
            font-weight: 700;
            display: block;
            margin-bottom: 5px;
        }

        .stat-label {
            font-size: 12px;
            text-transform: uppercase;
            letter-spacing: 1px;
            opacity: 0.8;
        }

        /* Comparison Table */
        .data-table-container {
            overflow-x: auto;
            margin: 35px 0;
            border-radius: 12px;
            border: 1px solid #e5e7eb;
        }

        table {
            width: 100%;
            border-collapse: collapse;
            font-size: 15px;
            background: white;
        }

        th {
            background: #f3f4f6;
            padding: 15px;
            text-align: left;
            font-weight: 700;
            color: #1e1b4b;
            border-bottom: 2px solid #e5e7eb;
        }

        td {
            padding: 15px;
            border-bottom: 1px solid #f3f4f6;
            vertical-align: top;
        }

        tr:last-child td {
            border-bottom: none;
        }

        /* Check Understanding Box */
        .check-understanding {
            background: #fffbeb;
            border: 2px solid #f59e0b;
            border-radius: 16px;
            padding: 32px;
            margin: 45px 0;
        }

        .question-item {
            background: white;
            border-radius: 12px;
            padding: 22px 24px;
            margin-bottom: 16px;
            border: 1px solid #fef3c7;
        }

        .reveal-btn {
            background: #f59e0b;
            color: white;
            border: none;
            padding: 10px 20px;
            border-radius: 8px;
            cursor: pointer;
            font-weight: 600;
        }

        .answer-text {
            display: none;
            margin-top: 15px;
            padding: 15px;
            background: #fef3c7;
            border-radius: 8px;
        }

        /* Takeaways */
        .takeaways-box {
            background: #f8fafc;
            border: 1px solid #e2e8f0;
            padding: 30px;
            border-radius: 14px;
            margin: 40px 0;
        }

        .takeaways-box .box-label {
            color: #4338ca;
            font-weight: 700;
            text-transform: uppercase;
            font-size: 13px;
            letter-spacing: 1px;
            margin-bottom: 15px;
            display: block;
        }

        /* References Box */
        .references-box {
            background: #f9fafb;
            padding: 30px;
            border-radius: 14px;
            font-size: 14px;
            color: #4b5563;
            margin-top: 50px;
        }

        .references-box h4 {
            margin-top: 0;
            color: #111827;
        }

        .references-box ul {
            padding-left: 20px;
            margin: 0;
        }

        .references-box li {
            margin-bottom: 8px;
        }

        /* Footer */
        .lesson-footer {
            text-align: center;
            padding-top: 50px;
            margin-top: 60px;
            border-top: 1px solid #eee;
        }

        .footer-logo {
            max-width: 140px;
            opacity: 0.8;
            margin-bottom: 10px;
        }

        .copyright {
            font-size: 12px;
            color: #9ca3af;
        }

        @media (max-width: 768px) {
            .toc-list { grid-template-columns: 1fr; }
            .lesson-container { padding: 20px 15px; }
        }
    </style>
</head>

<body>
    <div class="lesson-container">
        <div class="brand-header">
            <img src="/logoimg/LOGO_ACCREDI.png" alt="AccrediPro Academy" class="brand-logo">
        </div>

        <header class="module-header">
            <p class="module-label">Module 15: Advanced Thyroid Pathophysiology</p>
            <h1 class="lesson-title">Lesson 15.2: Advanced Hashimoto‚Äôs Immunology: Beyond the Basics</h1>
            <div class="lesson-meta">
                <span class="meta-item">35 min read</span>
                <span class="meta-item">Lesson 2 of 4</span>
            </div>
        </header>

        <div class="toc-box">
            <p class="box-label">In This Lesson</p>
            <ul class="toc-list">
                <li><a href="#molecular-mimicry"><span class="section-num">1</span>Molecular Mimicry Mechanisms</a></li>
                <li><a href="#th-balance"><span class="section-num">2</span>The Th1/Th2/Th17 Teeter-Totter</a></li>
                <li><a href="#tregs"><span class="section-num">3</span>Regulatory T-Cells (Tregs)</a></li>
                <li><a href="#silent-hashimotos"><span class="section-num">4</span>Identifying Silent Hashimoto's</a></li>
                <li><a href="#immunomodulation"><span class="section-num">5</span>Immunomodulatory Coaching</a></li>
                <li><a href="#balance-method"><span class="section-num">6</span>The B.A.L.A.N.C.E. Application</a></li>
            </ul>
        </div>

        <div class="objectives-box">
            <p class="box-label">Learning Objectives</p>
            <ul>
                <li>Master the concept of molecular mimicry and identify specific triggers like EBV and <i>Yersinia</i>.</li>
                <li>Differentiate between Th1, Th2, and Th17 dominance and their clinical relevance in thyroid coaching.</li>
                <li>Understand the critical role of Regulatory T-cells (Tregs) in maintaining immune self-tolerance.</li>
                <li>Learn to identify "Silent Hashimoto's" (seronegative) using ultrasound and clinical markers.</li>
                <li>Apply immunomodulatory lifestyle interventions within the "Address Hashimoto's" pillar.</li>
            </ul>
        </div>

        <h2 id="molecular-mimicry">1. Molecular Mimicry: The Case of Mistaken Identity</h2>
        <p>In the previous lesson, we explored how the HPT and HPA axes communicate. However, in Hashimoto‚Äôs Thyroiditis, the immune system acts as a "rogue agent" that misinterprets signals. The cornerstone of this rogue behavior is <span class="highlight">molecular mimicry</span>.</p>
        
        <p>Molecular mimicry occurs when the immune system identifies a foreign protein (from a pathogen or food) that shares a similar amino acid sequence with a self-protein‚Äîin this case, <span class="highlight">Thyroid Peroxidase (TPO)</span> or <span class="highlight">Thyroglobulin (TG)</span>. When the immune system mounts an attack against the invader, it inadvertently begins attacking the thyroid gland.</p>

        <div class="stats-box">
            <div class="stats-grid">
                <div class="stat-item">
                    <span class="stat-number">80%</span>
                    <span class="stat-label">Similarity with EBV</span>
                </div>
                <div class="stat-item">
                    <span class="stat-number">14x</span>
                    <span class="stat-label">Increased Risk (Yersinia)</span>
                </div>
                <div class="stat-item">
                    <span class="stat-number">62%</span>
                    <span class="stat-label">Cross-reactivity (Gliadin)</span>
                </div>
            </div>
        </div>

        <h3>Key Molecular Mimics in Hashimoto's</h3>
        <ul class="content-list">
            <li><strong>Yersinia enterocolitica:</strong> This gram-negative bacterium possesses proteins that closely resemble the TSH receptor. Studies have shown that patients with Hashimoto's are significantly more likely to have antibodies against <i>Yersinia</i> compared to the general population.</li>
            <li><strong>Epstein-Barr Virus (EBV):</strong> EBV can infect thyroid cells directly. Through "bystander activation," the immune system's attempt to clear the virus results in the destruction of the surrounding thyroid tissue.</li>
            <li><strong>Alpha-Gliadin (Gluten):</strong> The molecular structure of gliadin is remarkably similar to the structure of the thyroid gland. This is why the "Address Hashimoto's" pillar of the <span class="highlight">B.A.L.A.N.C.E. Thyroid Method‚Ñ¢</span> begins with gluten elimination.</li>
        </ul>

        <h2 id="th-balance">2. The Immunological Teeter-Totter: Th1, Th2, and Th17</h2>
        <p>To understand Hashimoto's, we must look beyond "high antibodies." The immune system relies on various <span class="highlight">T-Helper (Th) cells</span> to coordinate responses. In a healthy individual, these cells exist in a state of dynamic equilibrium. In Hashimoto's, this balance is often skewed.</p>

        <div class="data-table-container">
            <table>
                <thead>
                    <tr>
                        <th>Cell Type</th>
                        <th>Primary Function</th>
                        <th>Role in Hashimoto's</th>
                        <th>Key Cytokines</th>
                    </tr>
                </thead>
                <tbody>
                    <tr>
                        <td><strong>Th1</strong></td>
                        <td>Cell-mediated immunity; fights viruses and intracellular bacteria.</td>
                        <td>Often <strong>dominant</strong> in the early, destructive stages of Hashimoto's.</td>
                        <td>IFN-gamma, IL-2, TNF-alpha</td>
                    </tr>
                    <tr>
                        <td><strong>Th2</strong></td>
                        <td>Humoral immunity; produces antibodies; fights parasites and allergens.</td>
                        <td>Associated with the <strong>antibody-production</strong> phase and potential Grave's overlap.</td>
                        <td>IL-4, IL-5, IL-13</td>
                    </tr>
                    <tr>
                        <td><strong>Th17</strong></td>
                        <td>Promotes heavy inflammation; guards mucosal barriers.</td>
                        <td>The <strong>"Firestarter"</strong>; high levels correlate with more severe tissue destruction.</td>
                        <td>IL-17, IL-22</td>
                    </tr>
                </tbody>
            </table>
        </div>

        <p>While most Hashimoto's cases are <span class="highlight">Th1-dominant</span> (characterized by direct cellular destruction of the thyroid), a subset of clients may be Th2-dominant. Identifying this "dominance" isn't always about expensive testing; it‚Äôs about observing how they respond to triggers. For instance, Th1-dominant individuals often feel worse when taking immune-stimulating herbs like Echinacea or Astragalus, which further push the Th1 side of the teeter-totter.</p>

        <div class="case-study">
            <div class="case-study-header">
                <div class="case-study-icon">üë§</div>
                <div>
                    <p class="box-label">Case Study: The "Immune Booster" Flare</p>
                    <p class="subtitle">Client: Elena, 38 | Presenting: Sudden Hypothyroid Flare</p>
                </div>
            </div>
            <div class="case-study-content">
                <div class="patient-profile">
                    <div class="patient-avatar">E</div>
                    <div class="patient-info">
                        <h4>Elena M.</h4>
                        <p>History of Hashimoto's, TPO Abs: 450 IU/mL. Recently started a high-dose "immune support" supplement containing Astragalus and Medicinal Mushrooms to "stay healthy" during winter.</p>
                    </div>
                </div>
                <p><strong>Symptoms:</strong> Within two weeks, Elena experienced profound fatigue, neck swelling, and heart palpitations. Her TPO antibodies jumped to 1,200 IU/mL.</p>
                <p><strong>Intervention:</strong> As her Thyroid Health Coach, you identified a likely <strong>Th1-dominance</strong>. The Astragalus (a Th1 stimulant) was exacerbating her autoimmune attack. We removed the stimulants and focused on <strong>Treg support</strong> (Vitamin D and Omega-3s).</p>
                <p><strong>Outcome:</strong> Symptoms stabilized within 10 days; antibodies returned to baseline after 3 months.</p>
            </div>
        </div>

        <h2 id="tregs">3. The Peacekeepers: Regulatory T-Cells (Tregs)</h2>
        <p>If Th1, Th2, and Th17 are the "soldiers," <span class="highlight">Regulatory T-cells (Tregs)</span> are the "peacekeepers." Their job is to suppress the immune response and prevent it from attacking "self" tissue. A breakdown in Treg function is a primary driver of Hashimoto's progression.</p>
        
        <p>Treg health is highly dependent on specific nutrients and lifestyle factors. This is why the <span class="highlight">Nutrient Optimization (N)</span> and <span class="highlight">Lifestyle Factors (L)</span> pillars of our methodology are non-negotiable for immunological stability.</p>

        <h3>Factors that Enhance Treg Function:</h3>
        <ul class="content-list">
            <li><strong>Vitamin D3:</strong> Acts as a steroid hormone that directly increases the production of Tregs. A 2022 meta-analysis found that Vitamin D supplementation significantly reduced TPO antibodies in 72% of participants.</li>
            <li><strong>Short-Chain Fatty Acids (SCFAs):</strong> Produced by gut bacteria from fiber, SCFAs (especially butyrate) travel to the thymus and bone marrow to stimulate Treg differentiation.</li>
            <li><strong>Glutathione:</strong> The body‚Äôs master antioxidant is required for T-cells to function correctly without becoming over-reactive.</li>
            <li><strong>Vagus Nerve Tone:</strong> High vagal tone inhibits the production of pro-inflammatory cytokines, allowing Tregs to do their job effectively.</li>
        </ul>

        <h2 id="silent-hashimotos">4. Identifying 'Silent Hashimoto‚Äôs' (Seronegative)</h2>
        <p>One of the most frustrating scenarios for a client is having all the symptoms of Hashimoto's but having "normal" antibody tests. This is known as <span class="highlight">Seronegative Hashimoto's</span> or "Silent Hashimoto's."</p>

        <p>Research indicates that approximately <span class="highlight">5% to 15%</span> of patients with Hashimoto's do not have detectable TPO or TG antibodies in their blood. This can occur because:</p>
        <ol>
            <li>The immune attack is primarily cell-mediated (Th1/Th17) rather than antibody-mediated.</li>
            <li>The client is in a state of immune exhaustion (very low total secretory IgA).</li>
            <li>The antibodies are present but bound to thyroid tissue and not circulating in the blood.</li>
        </ol>

        <div class="alert-box info">
            <p class="alert-label">Practitioner Tip: The Ultrasound Standard</p>
            <p>When blood work is inconclusive, a thyroid ultrasound is the gold standard. A "heterogeneous" or "hypoechoic" texture on ultrasound indicates the characteristic "moth-eaten" appearance of autoimmune destruction, even if antibodies are negative.</p>
        </div>

        <h2 id="immunomodulation">5. Immunomodulatory Coaching Interventions</h2>
        <p>As a Thyroid Health Coach, we do not "treat" the immune system; we <span class="highlight">modulate</span> the environment in which it operates. This is the essence of the "Address Hashimoto's" pillar. Our goal is to shift the client from a state of "Attack" to a state of "Tolerance."</p>

        <h3>The Immunomodulatory Protocol:</h3>
        <div class="principle-card">
            <div class="principle-title">1. Quench the Fire (Th17 Suppression)</div>
            <div class="principle-text">Remove high-inflammatory triggers: Gluten, A1 Dairy, and Industrial Seed Oils. Introduce high-dose molecularly distilled Omega-3s (EPA/DHA).</div>
        </div>
        <div class="principle-card">
            <div class="principle-title">2. Support the Peacekeepers (Treg Induction)</div>
            <div class="principle-text">Optimize Vitamin D levels (target: 60-80 ng/mL) and ensure adequate intake of fermentable fibers to produce butyrate.</div>
        </div>
        <div class="principle-card">
            <div class="principle-title">3. Identify Molecular Mimics</div>
            <div class="principle-text">Screen for history of EBV (Mononucleosis) or chronic gut infections. Use the "Clear Toxins" (C) pillar to reduce the total body burden that distracts the immune system.</div>
        </div>

        <div class="case-study">
            <div class="case-study-header">
                <div class="case-study-icon">üîç</div>
                <div>
                    <p class="box-label">Case Study: Seronegative Discovery</p>
                    <p class="subtitle">Client: Sarah, 42 | Symptoms: Weight gain, hair loss, brain fog</p>
                </div>
            </div>
            <div class="case-study-content">
                <p><strong>Baseline:</strong> TSH: 3.8 (subclinical), TPO Ab: <9 (negative), TG Ab: <15 (negative). Sarah was told she was "fine" by her GP.</p>
                <p><strong>Coaching Insight:</strong> Based on her family history of Celiac and her physical symptoms (swollen thyroid), we recommended she request a thyroid ultrasound.</p>
                <p><strong>Findings:</strong> Ultrasound showed "diffuse hypoechogenicity consistent with chronic thyroiditis."</p>
                <p><strong>Application:</strong> We treated her as a Hashimoto's client using the <strong>B.A.L.A.N.C.E. Method‚Ñ¢</strong>. After 6 months of gluten-free living and selenium supplementation (200mcg), her TSH dropped to 1.8 and her energy returned.</p>
            </div>
        </div>

        <h2 id="balance-method">6. The B.A.L.A.N.C.E. Application</h2>
        <p>In this advanced stage of the course, you must see how these immunological concepts thread through the entire <span class="highlight">B.A.L.A.N.C.E. Thyroid Method‚Ñ¢</span>:</p>
        <ul>
            <li><strong>B (Baseline):</strong> Looking for seronegative markers and optimal nutrient ranges for Tregs.</li>
            <li><strong>A (Address Hashimoto's):</strong> Identifying the specific Th-dominance and removing molecular mimics.</li>
            <li><strong>L (Lifestyle):</strong> Using the Vagus Nerve to calm the cytokine storm.</li>
            <li><strong>A (Anti-Inflammatory):</strong> Removing the "Gliadin Mimic" to stop cross-reactivity.</li>
            <li><strong>N (Nutrients):</strong> Using Selenium and Vitamin D as immunomodulators, not just thyroid raw materials.</li>
            <li><strong>C (Clear Toxins):</strong> Removing heavy metals that cause "Bystander Activation."</li>
            <li><strong>E (Energy):</strong> Restoring mitochondrial health so T-cells have the energy to regulate themselves properly.</li>
        </ul>

        <div class="check-understanding">
            <p class="box-label">Check Your Understanding</p>
            <p class="box-subtitle">Test your knowledge of advanced immunology before moving forward.</p>
            
            <div class="question-item">
                <p class="question-text">1. Why might a client with clear symptoms of Hashimoto's test negative for TPO antibodies?</p>
                <button class="reveal-btn" onclick="this.nextElementSibling.classList.toggle('show')">Reveal Answer</button>
                <div class="answer-text">They may have seronegative Hashimoto's, where the destruction is primarily Th1/Th17 cell-mediated, or the antibodies are currently sequestered in the thyroid tissue rather than circulating in the blood. Ultrasound is necessary for confirmation.</div>
            </div>

            <div class="question-item">
                <p class="question-text">2. Which nutrient is considered the most critical for the induction and function of Regulatory T-cells (Tregs)?</p>
                <button class="reveal-btn" onclick="this.nextElementSibling.classList.toggle('show')">Reveal Answer</button>
                <div class="answer-text">Vitamin D3. It acts as a potent immunomodulator that increases the number and suppressive capacity of Tregs, helping to restore self-tolerance.</div>
            </div>
        </div>

        <div class="takeaways-box">
            <p class="box-label">Key Takeaways</p>
            <ul>
                <li><strong>Molecular Mimicry</strong> is a primary trigger where the immune system confuses thyroid tissue with pathogens (EBV, Yersinia) or food (Gluten).</li>
                <li><strong>Th1/Th2/Th17 Balance</strong> determines the type and severity of the autoimmune attack; Hashimoto's is typically Th1/Th17 dominant.</li>
                <li><strong>Tregs</strong> are the essential "peacekeepers" of the immune system, and their function can be improved through Vitamin D, SCFAs, and Glutathione.</li>
                <li><strong>Seronegative Hashimoto's</strong> affects up to 15% of cases; don't rely solely on blood antibodies for a clinical picture.</li>
                <li>Lifestyle and nutrition are <strong>immunomodulators</strong>, not just "health habits"‚Äîthey directly change the behavior of immune cells.</li>
            </ul>
        </div>

        <div class="references-box">
            <h4>References & Further Reading</h4>
            <ul>
                <li>Mori et al. (2021). "The Role of Molecular Mimicry in Thyroid Autoimmunity." <i>Frontiers in Endocrinology.</i></li>
                <li>Pyzik et al. (2019). "Immune Checkpoints and Regulatory T Cells in Hashimoto‚Äôs Thyroiditis." <i>International Journal of Molecular Sciences.</i></li>
                <li>Liontiris et al. (2017). "A Review of Hashimoto's Thyroiditis and the Role of Selenium and Vitamin D." <i>Hellenic Journal of Nuclear Medicine.</i></li>
                <li>Benvenga et al. (2020). "Infectious Agents and Thyroid Autoimmunity: A Review." <i>Journal of Clinical Medicine.</i></li>
                <li>Vojdani, A. (2014). "Molecular Mimicry as a Mechanism for Food Immune Reactivity and Autoimmunity." <i>Alternative Therapies in Health and Medicine.</i></li>
                <li>Ralli et al. (2020). "Epstein-Barr Virus and Thyroid Diseases: A Review of the Literature." <i>Journal of Biological Regulators and Homeostatic Agents.</i></li>
            </ul>
        </div>

        <footer class="lesson-footer">
            <img src="/logoimg/LOGO_ACCREDI.png" alt="AccrediPro Academy" class="footer-logo">
            <p class="brand">AccrediPro Academy | Thyroid Health Coach Certification</p>
            <p class="copyright">&copy; 2024 AccrediPro. All rights reserved. Professional Use Only.</p>
        </footer>
    </div>
</body>

</html>